PRO-BANTHINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pro-banthine, and what generic alternatives are available?
Pro-banthine is a drug marketed by Gd Searle Llc and Shire and is included in two NDAs.
The generic ingredient in PRO-BANTHINE is propantheline bromide. There are seven drug master file entries for this compound. Additional details are available on the propantheline bromide profile page.
Summary for PRO-BANTHINE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 70 |
Patent Applications: | 2,314 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PRO-BANTHINE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PRO-BANTHINE
US Patents and Regulatory Information for PRO-BANTHINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gd Searle Llc | PRO-BANTHINE | propantheline bromide | INJECTABLE;INJECTION | 008843-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Shire | PRO-BANTHINE | propantheline bromide | TABLET;ORAL | 008732-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Shire | PRO-BANTHINE | propantheline bromide | TABLET;ORAL | 008732-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |